Cronos (CRON) Cash from Investing Activities (2019 - 2026)
Cronos (CRON) recorded quarterly Cash from Investing Activities of $38.0 million in Q1 2026, up 1266.97% quarter-over-quarter from $2.8 million in Q4 2025, and up 168.7% on a YoY basis from $14.2 million in Q1 2025.
Cronos (CRON) Cash from Investing Activities (2019 - 2026) Analysis & Trends
Cronos' Cash from Investing Activities history runs 8 years deep, the most recent figure standing at $38.0 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 168.7% year-over-year to $38.0 million; the TTM figure through Mar 2026 stood at $16.8 million (up 124.12% YoY), while the FY2025 annual figure was -$76.6 million, down 143.71% from the prior year.
- Cash from Investing Activities was $38.0 million for Q1 2026 at Cronos, up from $2.8 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $189.6 million in Q1 2024 to a low of -$303.8 million in Q1 2023.
- Historically, Cash from Investing Activities has averaged $4.4 million across 5 years, with a median of -$818000.0 in 2024.
- Biggest YoY gain for Cash from Investing Activities was 231.33% in 2023; the steepest drop was 303912.0% in 2023.
- A 5-year view of Cash from Investing Activities shows it stood at $158.5 million in 2022, then plunged by 48.32% to $81.9 million in 2023, then sank by 106.14% to -$5.0 million in 2024, then soared by 155.29% to $2.8 million in 2025, then surged by 1266.97% to $38.0 million in 2026.
- The last three Cash from Investing Activities figures came in at $38.0 million (Q1 2026), $2.8 million (Q4 2025), and -$23.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 229.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -87.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 743.70 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -506.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -60.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.08 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -15.45 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 25.99 Mn |
| 10 | Cronos | 1.06 Bn | 292.44 Mn | 19.15 Mn | 38.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.03 Mn |
| Mar 31, 2026 | 38.03 Mn |
| Dec 31, 2025 | 2.78 Mn |
| Dec 31, 2025 | 2.78 Mn |
| Sep 30, 2025 | -23.00 Mn |
| Sep 30, 2025 | -23.00 Mn |
| Jun 30, 2025 | -983,000.00 |
| Jun 30, 2025 | -983,000.00 |
| Mar 31, 2025 | -55.36 Mn |
| Mar 31, 2025 | -55.36 Mn |
| Dec 31, 2024 | -5.03 Mn |
| Dec 31, 2024 | -5.03 Mn |
| Sep 30, 2024 | -818,000.00 |
| Sep 30, 2024 | -818,000.00 |
| Jun 30, 2024 | -8.56 Mn |
| Jun 30, 2024 | -8.56 Mn |
| Mar 31, 2024 | 189.56 Mn |
| Mar 31, 2024 | 189.56 Mn |
| Dec 31, 2023 | 81.89 Mn |
| Dec 31, 2023 | 81.89 Mn |